FOXO1 and gastric cancer: Similarly, upregulated LINE derived-miR-552 also functions as an oncogenic miRNA, as an accelerator of gastric cancer progression, increased metastasis, and worsens therapeutic outcomes by targeting forkhead box O1 (FOXO1) and modulating the PI3K/AKT pathway [205].